AB Science SA (Euronext - FR0010557264 - AB) announces today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) granted orphan drug status to AB8939 for the ...

They said the EU should “rethink its pricing policy” in response to a drop in the proportion of money it spends on drugs compared with America. The letter – which was signed by Emma Walmsley ...

The first such medicine to be allowed in the EU, the drug was approved in line with the "positive scientific assessment of the European Medicines Agency," the commission said in a statement.

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. European pharmaceutical bosses have called on the EU to increase drug prices towards the much higher levels ...

Idorsia has become the first drugmaker in the EU to claim approval for ... the day after dosing than the rival drugs, because it has a shorter half-life. Belsomra has a box warning on its label ...

European pharmaceutical bosses have called on the EU to increase drug prices towards the much higher levels paid by the US, saying it will encourage innovation. In a letter to the Financial Times ...

drug developers are now able to drive more patient-facing outcomes, by supporting it with effective evidence-based decision-making across the product life cycle. At a point of increasing maturity ...

Brussels – Alzheimer’s: the European Union is writing a new chapter in its common health policy by authorizing, under strict conditions, the marketing of Leqembi, a drug to treat the disease in its ...

April 15 (Reuters) - The European Commission on Tuesday authorized the use of Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab drug to treat some patients with mild cognitive ...

Enteroviruses are a group of viruses that cause everything from the common cold to meningitis, polio, type 1 diabetes, and ...